"Area Under Curve" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A statistical means of summarizing information from a series of measurements on one individual. It is frequently used in clinical pharmacology where the AUC from serum levels can be interpreted as the total uptake of whatever has been administered. As a plot of the concentration of a drug against time, after a single dose of medicine, producing a standard shape curve, it is a means of comparing the bioavailability of the same drug made by different companies. (From Winslade, Dictionary of Clinical Research, 1992)
Descriptor ID |
D019540
|
MeSH Number(s) |
E05.318.740.200 G03.787.101 G07.690.725.064 N06.850.520.830.200
|
Concept/Terms |
Area Under Curve- Area Under Curve
- Area Under Curves
- Curve, Area Under
- Curves, Area Under
- Under Curve, Area
- Under Curves, Area
- AUC
|
Below are MeSH descriptors whose meaning is more general than "Area Under Curve".
Below are MeSH descriptors whose meaning is more specific than "Area Under Curve".
This graph shows the total number of publications written about "Area Under Curve" by people in this website by year, and whether "Area Under Curve" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2002 | 0 | 1 | 1 |
2004 | 0 | 2 | 2 |
2005 | 0 | 2 | 2 |
2006 | 0 | 3 | 3 |
2007 | 0 | 2 | 2 |
2008 | 0 | 1 | 1 |
2009 | 0 | 4 | 4 |
2010 | 0 | 2 | 2 |
2011 | 0 | 3 | 3 |
2012 | 0 | 3 | 3 |
2013 | 0 | 6 | 6 |
2014 | 0 | 3 | 3 |
2015 | 0 | 4 | 4 |
2016 | 0 | 10 | 10 |
2017 | 0 | 152 | 152 |
2018 | 1 | 153 | 154 |
2019 | 0 | 34 | 34 |
2020 | 0 | 41 | 41 |
2021 | 0 | 42 | 42 |
To return to the timeline, click here.
Below are the most recent publications written about "Area Under Curve" by people in Profiles.
-
Clinical significance and molecular mechanism of angiotensin-converting enzyme 2 in hepatocellular carcinoma tissues. Bioengineered. 2021 12; 12(1):4054-4069.
-
Automated processing of thermal imaging to detect COVID-19. Sci Rep. 2021 09 01; 11(1):17489.
-
Validation of parsimonious prognostic models for patients infected with COVID-19. BMJ Health Care Inform. 2021 Sep; 28(1).
-
Diagnostic performance and clinical implications of rapid SARS-CoV-2 antigen testing in Mexico using real-world nationwide COVID-19 registry data. PLoS One. 2021; 16(8):e0256447.
-
Phase I study in healthy participants to evaluate safety, tolerability, and pharmacokinetics of inhaled nezulcitinib, a potential treatment for COVID-19. Clin Transl Sci. 2021 11; 14(6):2556-2565.
-
Immunometabolic signatures predict risk of progression to sepsis in COVID-19. PLoS One. 2021; 16(8):e0256784.
-
D-dimer as a biomarker for assessment of COVID-19 prognosis: D-dimer levels on admission and its role in predicting disease outcome in hospitalized patients with COVID-19. PLoS One. 2021; 16(8):e0256744.
-
Regional performance variation in external validation of four prediction models for severity of COVID-19 at hospital admission: An observational multi-centre cohort study. PLoS One. 2021; 16(8):e0255748.
-
Clinical validation of an open-access SARS-COV-2 antigen detection lateral flow assay, compared to commercially available assays. PLoS One. 2021; 16(8):e0256352.
-
The prognostic value of the SOFA score in patients with COVID-19: A retrospective, observational study. Medicine (Baltimore). 2021 Aug 13; 100(32):e26900.